VTAK
Catheter Precision, Inc.
Key Financials
Gross Profit
$756000
↑ 100.0%
EPS (Diluted)
$-25.98
↑ 89.5%
Revenue
$819000
↑ 95.0%
Operating Income
$-21143000
↓ 88.1%
Total Assets
$15.9M
↓ 42.9%
Net Income
$-17183000
↓ 3.2%
Total Liabilities
$9.2M
↓ 42.5%
Shareholders' Equity
$7.1M
↓ 40.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| 8-K | 7/31/2026 | View on SEC |
| 8-K/A | 7/29/2026 | View on SEC |
| SCHEDULE 13G | 7/20/2026 | View on SEC |
| 8-K | 7/15/2026 | View on SEC |
| EFFECT | 7/10/2026 | View on SEC |
| 424B3 | 7/10/2026 | View on SEC |
| S-1/A | 7/6/2026 | View on SEC |
| SCHEDULE 13G | 6/26/2026 | View on SEC |
| S-1 | 6/22/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VTAK |
| Company Name | Catheter Precision, Inc. |
| CIK | 1716621 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 973-691-2000 |